Le Lézard
Classified in: Science and technology
Subjects: PDT, MAT

Foxy.ai Announces Groundbreaking AI Companion Platform with $1.5M in Funding and Celebrity Investors


LOS ANGELES, March 20, 2024 /PRNewswire/ -- Foxy.ai, a cutting-edge AI companion platform, proudly unveils its latest milestone: The successful closure of a $1.5 million funding round. Backed by a host of renowned celebrity investors, billionaires, and tech industry heavyweights, Foxy.ai is set to revolutionize digital interactions between fans and their favorite influencers.

At the core of Foxy.ai's innovative model is its collaboration with celebrities and influencers to craft hyper-realistic AI girlfriend versions of themselves. These AI outputs are designed to engage with fans on a deeper level, facilitating seamless exchanges of messages, calls, and images, available in 30 languages and around the clock.

This unique approach guarantees personalized connections that go beyond traditional boundaries. With influencers eagerly awaiting their spot on the platform's exclusive, invite-only roster, Foxy.ai's exceptional features and unmatched capabilities are poised to reshape digital interactions, ushering in a new era of meaningful connections.

Foxy.ai emerges as an industry frontrunner by excelling in AI-enhanced imagery. The platform boasts the creation of the most lifelike AI photos of individuals globally, rendering them virtually indistinguishable from their real-life counterparts.

Foxy.ai operates as an invitation-only platform that has significant appeal for influencers across industries. Celebrities are interested in the opportunity for deep, authentic connections with fans and the considerable earning potential it offers. With a waitlist exceeding 500 individuals and influencers eyeing the benefits, Foxy.ai is poised for remarkable expansion and impact.

About Foxy.ai: Foxy.ai is a pioneering AI companion platform that leverages advanced technology to create genuine connections between influencers and their audience. Through ultra-realistic AI versions of celebrities, groundbreaking features, and a focus on authenticity, Foxy.ai is transforming the creator economy.

For more information on Foxy.ai and its offerings, visit Foxy.ai.

Media Contact: GR0 Agency, [email protected], https://gr0.com/

SOURCE Foxy AI


These press releases may also interest you

at 03:30
New Electric Mountain Bike Player Amflow Enters Market, unveiling its Revolutionary First Bike powered by DJI Avinox at Eurobike 2024
Amflow, the eMTB expert that builds e-bikes from heart to body, today marks its entry into the industry with the launch of the Amflow PL. Providing a significantly robust 850 W of peak power and weighing in at an industry leading level of ultra-light...

at 03:17
Daniels Manufacturing Corporation Acquires MCD-Tools GmbH
Daniels Manufacturing Corporation® (DMC®) is proud to announce the successful acquisition of MCD-Tools GmbH, a leading tool distribution and repair company based near Frankfurt, Germany. DMC's acquisition of MCD-Tools allows DMC to form DMC Europe...

at 03:05
NIQ Activate Platform Now Available on Microsoft Azure Marketplace
NielsenIQ (NIQ) today announced the availability of NIQ Activate in the Microsoft Azure Marketplace, an online store providing applications and services for use on Azure. NIQ customers can now take advantage of the productive and trusted Azure cloud...

at 03:05
Owkin, an AI-Biotech Unicorn, Brings Its Cutting-Edge AI to Germany, Austria and Switzerland to Accelerate Research
Owkin, the first end-to-end AI-biotech unicorn that provides best-in-class AI-driven precision drug discovery, development and diagnostics, has announced its expansion into the DACH region (Germany, Austria and Switzerland) following partnerships...

at 03:05
Manhattan Associates Celebrates Best Sustainability Initiative Win at the 2024 EMEA VIP Awards
Manhattan Associates today announced that it has been named winner of the VIP Awards' Best Sustainability Initiative category for 2024. Selected from a competitive group of nominees, Manhattan Active® Supply Chain technology was chosen because of...

at 03:05
Delta-Fly Pharma Inc.: Notice of initiation of patients enrollment in Phase III Pivotal comparative clinical trial of DFP-14323
We are excited to share our latest development status. We are pleased to announce that the enrollment of patients in the Phase III clinical trial of DFP-14323 in combination with Afatinib (20 mg/day) versus Afatinib (40 mg/day) alone in stage...

More news about Science and technology...


News published on and distributed by: